Biblio

Export 14 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Vellas, Bruno  [Clear All Filters]
Journal Article
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria., Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
M. Kim, Nevado-Holgado, A., Whiley, L., Snowden, S. G., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Thambisetty, M., Dobson, R. J. B., Powell, J. F., Lupton, M. K., Simmons, A., Velayudhan, L., Lovestone, S., Proitsi, P., and Legido-Quigley, C., Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease., J Alzheimers Dis, vol. 60, no. 3, pp. 809-817, 2017.
K. Bennys, Gabelle, A., Berr, C., De Verbizier, D., Andrieu, S., Vellas, B., and Touchon, J., Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study., J Alzheimers Dis, vol. 58, no. 1, pp. 87-97, 2017.
L. Shi, Winchester, L. M., Liu, B. Y., Killick, R., Ribe, E. M., Westwood, S., Baird, A. L., Buckley, N. J., Hong, S., Dobricic, V., Kilpert, F., Franke, A., Kiddle, S., Sattlecker, M., Dobson, R., Cuadrado, A., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Kate, M. Ten, Scheltens, P., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Alcolea, D., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Teunissen, C. E., Freund-Levi, Y., Frölich, L., Legido-Quigley, C., Barkhof, F., Blennow, K., Rasmussen, K. Laura, Nordestgaard, B. Grønne, Frikke-Schmidt, R., Nielsen, S. Fallgaard, Soininen, H., Vellas, B., Kloszewska, I., Mecocci, P., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, Bertram, L., Nevado-Holgado, A. J., and Lovestone, S., Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
J. K. Chhetri, Barreto, Pde Souto, Cantet, C., Pothier, K., Cesari, M., Andrieu, S., Coley, N., and Vellas, B., Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores., J Alzheimers Dis, vol. 64, no. 1, pp. 71-78, 2018.
H. Basselerie, Bracoud, L., Zeestraten, E., Bouguen, E., Kiyasova, V., Pueyo, M., Cognard, C., Dumas, H., Gramada, R., Ousset, P. Jean, Vellas, B., and Bonneville, F., Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease., J Alzheimers Dis, vol. 60, no. 1, pp. 253-262, 2017.
M. Sattlecker, Khondoker, M., Proitsi, P., Williams, S., Soininen, H., Kłoszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., and Dobson, R. Jb, Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1105-14, 2016.
S. Dardenne, Delrieu, J., Sourdet, S., Cantet, C., Andrieu, S., Mathiex-Fortunet, H., Fougère, B., and Vellas, B., Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1., J Alzheimers Dis, vol. 60, no. 4, pp. 1567-1578, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A., A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
M. K. Lupton, Benyamin, B., Proitsi, P., Nyholt, D. R., Ferreira, M. A., Montgomery, G. W., Heath, A. C., Madden, P. A., Medland, S. E., Gordon, S. D., Lovestone, S., Tsolaki, M., Kloszewska, I., Soininen, H., Mecocci, P., Vellas, B., Powell, J. F., Bush, A. I., Wright, M. J., Martin, N. G., and Whitfield, J. B., No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease., J Alzheimers Dis, vol. 59, no. 1, pp. 85-99, 2017.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home., J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study., J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.